ELUFREZ Trademark

Trademark Overview


On Thursday, March 7, 2019, a trademark application was filed for ELUFREZ with the United States Patent and Trademark Office. The USPTO has given the ELUFREZ trademark a serial number of 79255628. The federal status of this trademark filing is REGISTERED as of Tuesday, November 12, 2019. This trademark is owned by Glaxo Group Limited. The ELUFREZ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines
elufrez

General Information


Serial Number79255628
Word MarkELUFREZ
Filing DateThursday, March 7, 2019
Status700 - REGISTERED
Status DateTuesday, November 12, 2019
Registration Number5905903
Registration DateTuesday, November 12, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, April 5, 2019NON-FINAL ACTION WRITTEN
Thursday, March 28, 2019SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Wednesday, April 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 3, 2019ASSIGNED TO EXAMINER
Saturday, April 6, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, April 9, 2019APPLICATION FILING RECEIPT MAILED
Monday, April 29, 2019REFUSAL PROCESSED BY MPU
Monday, April 29, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 17, 2019REFUSAL PROCESSED BY IB
Friday, July 12, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 18, 2019ASSIGNED TO LIE
Thursday, July 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 7, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 7, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 7, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, August 27, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, August 23, 2019NOTIFICATION PROCESSED BY IB
Tuesday, August 27, 2019PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2019REGISTERED-PRINCIPAL REGISTER
Friday, March 6, 2020FINAL DISPOSITION PROCESSED
Thursday, May 2, 2024INTERNATIONAL REGISTRATION RENEWED
Wednesday, February 12, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, March 6, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 24, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, July 23, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, June 5, 2025NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, November 12, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED